The epidemiology of multiple sclerosis in Devon: A comparison of the new and old classification criteria

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 1, 2004, Pages 56-60

  Fox, C M ^a   Bensa, S ^a   Bray, I ^b   Zajicek, J P ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; ENGLAND; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PRACTICE GUIDELINES; PREVALENCE;

EID: 0347125215     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Limburg CC. The geographical distribution of multiple sclerosis and its estimated prevalence in the United States. In: Multiple sclerosis and the demyelinating diseases. Proceedings of the Association of Research into Nervous and Mental Disease, vol 28. Baltimore: Williams and Wilkins, 1950:15-24.
2. Compston A. Distribution of multiple sclerosis. In: Compston A, Ebers G, Lassman H, et al, eds. McAlpine's Multiple sclerosis. Edinburgh: Churchill Livingstone, 1998:63-100.
3. Kurtzke JF. A reassessment of the distribution of multiple sclerosis, parts 1 and 2. Acta Neurol Scand 1975;51:110-57.
4. Shepherd DI, Downie AW. Prevalence of multiple sclerosis in north-east Scotland. BMJ 1978;2:314-16.
5. Shepherd DI, Downie AW. A further prevalence study of multiple sclerosis in norm east Scotland. J Neurol Neurosurg Psychiatry 1980;43:310-15.
6. Poskonzer DC, Prenny LB, Sheriden JL, et al. Multiple sclerosis in the Orkney and Shetland Islands. 1. Epidemiology, clinical factors and methodology. J Epidemiol Community Health 1980;34:229-39.
7. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998;64:730-5.
8. Forbes RB, Wilson SV, Swingler RJ. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist? J Neurol 1999;246:1033-40.
9. McDonnell GV, Hawkins SA. An epidemiologic study of study of multiple sclerosis in Northern Ireland. Neurology 1998;50:423-8.
10. Forbes RB, Swingler RJ, Hawkins SA, et al. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1999;52:214-18.
11. McDonnell GV, Hawkins SA. Multiple sclerosis in Northern Ireland: a historical and global perspective. Ulster Med J 2000;69:97-105.
12. Swingler RJ, Compston D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986;49:1115-24.
13. Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995;58:2-6.
14. Rice-Oxley M, Williams ES, Rees JE. A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry 1995;58:27-30.
15. Allison RS, Millar JHD. Prevalence and familial incidence of disseminated sclerosis (A report to the Northern Ireland Hospitals Authority on the results of a three year survey). Ulster Med J 1954;23:5-27.
16. Poser CM, Paty D, Scheinburg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
17. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:122-7.
18. Troceline. Office for National Statistics. Southpart, UK.
19. Hook EB, Regal RR. The value of capture-recapture methods even for apparent exhaustive surveys. Am J Epidemiol 1992;135:1060-7.
20. Poser CM, Brinar VV. Problems with diagnostic criteria for multiple sclerosis. Lancet 2001;358:1746-5.
21. Ebers G. New diagnostic criteria for MS. International Multiple Sclerosis Journal 2002;8:76-7.
22. Borkhof F, Filippi M, Miller DH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69.
23. Roberts MHW, Marin IP, McLellan DL, et al. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority. J Neurol Neurosurg Psychiatry 1990;53:55-9.
24. Mumford CJ, Fraser MB, Wood NW, et al. Multiple sclerosis in the Cambridge Health Authority. J Neurol Neurosurg Psychiatry 1992;55:877-82.
25. Robertson N, Deans J, Fraser M, et al. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry 1995;59:71-6.
26. Swingler RJ, Kirk PF, Darke C, et al. HLA and multiple sclerosis in south-east Wales. J Neurol Neurosurg Psychiatry 1987;50:1153-5.
27. Swingler RJ, Compston DAS. The prevalence of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1988;51:1520-4.
28. Shorpe G, Price SE, Last A, et al. Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey. J Neurol Neurosurg Psychiatry 1995;58:22-6.
29. Ford HL, Gerry E, Airey CM, et al. The prevalence of multiple sclerosis in the Leeds Health Authority. J Neurol Neurosurg Psychiatry 1998;64:605-10.
30. Shepherd DI, Summers A. Prevalence of multiple sclerosis in Rochdale. J Neurol Neurosurg Psychiatry 1996;61:415-17.
31. Hommond SR, Mcleod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities. Brain 1988;111:1-25.
32. Hommond SR, English D, de Wytt C, et al. The clinical profile of MS in Australia: a comparison between medium- and high-frequency prevalence zones. Neurology 1988;38:980-6.